Gliomas of the mesenchymal subtype are defined by high expression of chitinase 3-like 1 and MET5, as well as a high frequency of neurofibromatosis type 1 (NF1) mutation/deletion and low levels of NF1 mRNA (Verhaak et al., 2010). This evidence concerns the gene CHI3L1 and central nervous system cancer.